AptarGroup, Inc.
NYSE:ATRMedical - Instruments & Supplies
+$0.66 today
- Market cap
- $8.98B
- Beta
- 0.40
- P/E (TTM)
- 20.0
- EPS (TTM)
- $6.04
- Dividend yield
- 1.57%
Volume 0.34M
Average 0.51M
ATR EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
AptarGroup, Inc.NYSE: ATR
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) declines year over year
Q2 FY2026 EPS (Diluted) of $1.36 fell 18.6% year over year, behind the -4.8% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 21.4% from the prior quarter. Over 3 fiscal years it compounded at +17.9% a year.
Context
- EPS (Diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 6 analysts of $5.55 (-5.6%) for the fiscal year ending Dec 2026, a slowdown from the +6.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.36+21.4% QoQ
- Last fiscal yearDec 2025
- $5.88+6.3% YoY
- LTMJun 2026
- $5.53-4.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -18.6% | -23.4% | -4.8 pp |
| 1 year | +6.3% | -5.6% | -12.0 pp |
| 3-year CAGR | +17.9% | +5.3% | -12.6 pp |
| 5-year CAGR | +8.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 5.88 USD
- Year-over-year change
- +6.3%
- 4-year CAGR
- +13.0%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.88 | +6.3% |
| FY2024 | 2024-12-31 | 5.53 | +30.1% |
| FY2023 | 2023-12-31 | 4.25 | +18.4% |
| FY2022 | 2022-12-31 | 3.59 | -0.3% |
| FY2021 | 2021-12-31 | 3.60 | — |
EPS (Diluted) vs competitors
How ATR compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
- Its year-over-year change of -4.8% is the 5th highest of 7, against a peer median of +6.5%.
- Over three fiscal years its annual growth of +17.9% compares with a peer median of -4.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $24.08 USD | +3020.0% | +23.7% | |
| LTM Jun 2026 | $7.82 USD | +17.1% | -4.2% | |
| LTM Jun 2026 | $5.53 USD | -4.8% | +17.9% | |
| LTM Jun 2026 | $2.54 USD | -9.6% | -4.2% | |
| LTM Jun 2026 | $2.38 USD | +33.7% | -12.3% | |
| LTM Jun 2026 | €0.48 EUR | -4.0% | -2.6% | |
| LTM Sep 2026 | -$2.11 USD | -133.5% | -5.5% | |
| Peer median (excluding ATR) | — | +6.5% | -4.2% | |
Competitors are the stored peer set for ATR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.23B | 3.32B | 3.49B | 3.58B | 3.78B |
| Cost of Revenue | 2.07B | 2.16B | 2.22B | 2.23B | 2.66B |
| Gross Profit | 1.16B | 1.16B | 1.26B | 1.36B | 1.12B |
| Gross Margin | 35.8% | 35.0% | 36.2% | 37.8% | 29.6% |
| Research & Development | 99.8M | 0 | 0 | 0 | 105.1M |
| Selling, General & Admin | 551.24M | 544.26M | 565.78M | 582.23M | 499.94M |
| Operating Expenses | 809.34M | 784.57M | 859.38M | 859.01M | 605.04M |
| Depreciation & Amortization | 234.85M | 233.71M | 248.59M | 263.78M | 287.36M |
| EBITDA | 586.79M | 609.41M | 663.84M | 777.45M | 831.48M |
| EBITDA Margin | 18.2% | 18.3% | 19.0% | 21.7% | 22.0% |
| Operating Income | 347.35M | 379.27M | 404.02M | 496.5M | 512.34M |
| Operating Margin | 10.8% | 11.4% | 11.6% | 13.9% | 13.6% |
| Interest Income | 3.67M | 2.7M | 4.37M | 12.1M | 11.68M |
| Interest Expense | 30.28M | 40.83M | 40.42M | 43.9M | 52.74M |
| Other Income / Expenses | (25.69M) | (44.57M) | (29.19M) | (26.73M) | (20.96M) |
| Income Before Tax | 321.66M | 334.7M | 374.83M | 469.77M | 491.38M |
| Pre-Tax Margin | 10.0% | 10.1% | 10.7% | 13.1% | 13.0% |
| Income Tax Expense | 78.02M | 95.15M | 90.65M | 95.59M | 98.88M |
| Net Income | 244.1M | 239.29M | 284.49M | 374.54M | 392.79M |
| Net Margin | 7.6% | 7.2% | 8.2% | 10.5% | 10.4% |
| EPS (Basic) | 3.72 | 3.66 | 4.34 | 5.65 | 5.97 |
| EPS (Diluted) | 3.60 | 3.59 | 4.25 | 5.53 | 5.88 |
| Weighted Avg Shares | 65.66M | 65.4M | 65.62M | 66.33M | 65.74M |
| Weighted Avg Shares (Diluted) | 67.68M | 66.72M | 66.91M | 67.69M | 66.72M |
AptarGroup, Inc.
NYSE:ATR
Intrinsic Alpha fair value
Locked
Current Price
$141.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.